\BOOKMARK [1][-]{section.1}{Introduction}{}% 1
\BOOKMARK [1][-]{section.2}{Methods}{}% 2
\BOOKMARK [2][-]{subsection.2.1}{Datasets}{section.2}% 3
\BOOKMARK [2][-]{subsection.2.2}{Model}{section.2}% 4
\BOOKMARK [3][-]{subsubsection.2.2.1}{Spatial proteomics mixture model}{subsection.2.2}% 5
\BOOKMARK [3][-]{subsubsection.2.2.2}{Bayesian inference and convergence}{subsection.2.2}% 6
\BOOKMARK [3][-]{subsubsection.2.2.3}{Visualising patterns in uncertainty}{subsection.2.2}% 7
\BOOKMARK [3][-]{subsubsection.2.2.4}{Uncertainty Quantification}{subsection.2.2}% 8
\BOOKMARK [2][-]{subsection.2.3}{Validating computational approaches}{section.2}% 9
\BOOKMARK [3][-]{subsubsection.2.3.1}{Artificial masking of annotations to recover experimental design}{subsection.2.3}% 10
\BOOKMARK [3][-]{subsubsection.2.3.2}{The human protein atlas}{subsection.2.3}% 11
\BOOKMARK [3][-]{subsubsection.2.3.3}{Gene-Ontology term enrichment}{subsection.2.3}% 12
\BOOKMARK [1][-]{section.3}{Results}{}% 13
\BOOKMARK [2][-]{subsection.3.1}{Validating experimental design in hyperLOPIT}{section.3}% 14
\BOOKMARK [3][-]{subsubsection.3.1.1}{Mouse pluripotent embryonic stem cells}{subsection.3.1}% 15
\BOOKMARK [3][-]{subsubsection.3.1.2}{The human osteosarcoma \(U2OS\) cell-line}{subsection.3.1}% 16
\BOOKMARK [2][-]{subsection.3.2}{Uncovering additional sub-cellular structures}{section.3}% 17
\BOOKMARK [3][-]{subsubsection.3.2.1}{U2OS cell line revisited}{subsection.3.2}% 18
\BOOKMARK [3][-]{subsubsection.3.2.2}{Saccharomyces cerevisiae}{subsection.3.2}% 19
\BOOKMARK [3][-]{subsubsection.3.2.3}{HCMV infected fibroblast cells}{subsection.3.2}% 20
\BOOKMARK [3][-]{subsubsection.3.2.4}{Fibroblast cells without infection}{subsection.3.2}% 21
\BOOKMARK [2][-]{subsection.3.3}{Refining annotation in organeller maps}{section.3}% 22
\BOOKMARK [3][-]{subsubsection.3.3.1}{HeLa cells \(Itzhak et. al 2016\)}{subsection.3.3}% 23
\BOOKMARK [3][-]{subsubsection.3.3.2}{Mouse primary neuron cells \(Itzhak et. al 2017\)}{subsection.3.3}% 24
\BOOKMARK [3][-]{subsubsection.3.3.3}{HeLa cells \(Hirst et. al 2018\)}{subsection.3.3}% 25
\BOOKMARK [1][-]{section.4}{Discussion}{}% 26
\BOOKMARK [1][-]{section.5}{Appendix}{}% 27
\BOOKMARK [2][-]{subsection.5.1}{Handling label switching}{section.5}% 28
